Residual gammaH2AX foci as an indication of lethal DNA lesions.
about
MutS homologue hMSH5: role in cisplatin-induced DNA damage responseDNA damage signaling assessed in individual cells in relation to the cell cycle phase and induction of apoptosisIdentification of Small Molecule Proliferating Cell Nuclear Antigen (PCNA) Inhibitor That Disrupts Interactions with PIP-box Proteins and Inhibits DNA ReplicationDeregulation of DNA double-strand break repair in multiple myeloma: implications for genome stabilityCisplatin exposure damages resident stem cells of the mammalian inner ear.Functional Gene Analysis Reveals Cell Cycle Changes and Inflammation in Endothelial Cells Irradiated with a Single X-ray DoseCellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.Regular exercise participation improves genomic stability in diabetic patients: an exploratory study to analyse telomere length and DNA damage.Development and validation of 'AutoRIF': software for the automated analysis of radiation-induced foci.Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cellsOsSDS is essential for DSB formation in rice meiosisSuberoylanilide hydroxamic acid induces hypersensitivity to radiation therapy in acute myelogenous leukemia cells expressing constitutively active FLT3 mutants.Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugatesRNF8-independent Lys63 poly-ubiquitylation prevents genomic instability in response to replication-associated DNA damage.Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.Induction and persistence of radiation-induced DNA damage is more pronounced in young animals than in old animalsHigh throughput measurement of γH2AX DSB repair kinetics in a healthy human populationThe DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cellsIonizing radiation-induced foci persistence screen to discover enhancers of accelerated senescence.Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancerCancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced.H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues.Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapyQuantitative proteomics profiling of the poly(ADP-ribose)-related response to genotoxic stress.MCPIP is induced by cholesterol and participated in cholesterol-caused DNA damage in HUVEC.Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer.DNA double-strand break repair: a theoretical framework and its application.Variations in the Processing of DNA Double-Strand Breaks Along 60-MeV Therapeutic Proton Beams.Histone H2AX phosphorylation as a measure of DNA double-strand breaks and a marker of environmental stress and disease activity in lupus.Risk assessment of esophageal adenocarcinoma using γ-H2AX assayCombined effects of C225 and 125-iodine seed radiation on colorectal cancer cellsEpigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cellsSimvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth.Heterochromatin and the DNA damage response: the need to relax.Isogenic radiation resistant cell lines: development and validation strategies.Complex DNA Damage: A Route to Radiation-Induced Genomic Instability and Carcinogenesis.Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib.Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
P2860
Q24306821-4FB64F96-A2F3-40D2-ADDE-FBF8B77E23D2Q26822413-6319DC93-2B1D-4FD3-8A62-BA7D1BB2728EQ27677564-D35DC806-9F9C-4F05-87E3-F7FCE974E7D4Q28544696-2E82939F-E736-4661-BB93-F6410EAB6BBFQ30401803-498F7C09-F22E-4B36-BF3C-E6BCA666B760Q33602008-A0789D16-58CC-472C-8E2B-B4CAFB2442FFQ33670035-B5396E63-CF6F-4BAE-A651-28B0D5528153Q33830097-499FE25D-4F6F-46B8-A850-8ED953A410D8Q34142452-6A622061-90F5-4580-9933-F831D9816F40Q34977354-F0405C14-19D5-4921-86C1-EE8F1FA503E9Q35042146-7F715D2D-A1A9-4F9D-9F42-88F2674CA228Q35075792-D2178CAA-5A5E-4832-90E5-62C6632D079CQ35087681-A4B8FCE7-0417-4710-984E-8E5E159D2526Q35108533-E1BFBDD2-1FC4-4E3A-8550-90E986B20A77Q35141937-36775E10-91AF-4C41-8E60-F793C7093A1FQ35188232-75B7F292-06FE-44E9-85AA-00E97E22059DQ35202869-44797634-90D1-47EB-BDAD-0EC5E77B9BA6Q35556954-6904E699-9777-41F1-9F5C-56CC5C503D51Q35670160-51A6202A-5CF1-4784-98E6-8987FEF9D684Q35833060-5DE3D27D-AD96-4680-AEBC-D33977EEB380Q35896471-95E63180-40F1-43AD-B5BB-C5960073BE64Q35984652-5EE8B2DA-C9AC-43E3-B078-C2B81280F816Q36001923-3138E28F-264F-4846-A635-0452BCEA25BEQ36088241-84EDF60F-B165-4879-99F9-04D8DAAF0D56Q36228488-16183116-9AE5-4EF1-9A78-D4D1272293C0Q36261469-B85D19B3-362B-4001-B3DA-9A79B4886C4DQ36421123-618DC448-62A8-43DB-82A9-C684ABB96F82Q36521908-30AC0E4D-39D4-4EA2-ABBC-A3537EBAA040Q36596145-781ECE4B-B5AE-4475-BBFF-2BCD0BDF2EC8Q36823746-F9A31722-E52D-4CC0-902B-B611D37B097AQ36861623-BB1F7CA4-3E84-43A8-9176-F5FEB744BC81Q37298821-6E3089A5-2F66-4958-89D3-C43965B97084Q37365009-499891FC-4718-41D2-B9A9-DC39A8777459Q37708851-B42DF172-F049-417E-85D9-A07215CED02AQ37745474-523F9D3C-2F59-4D9E-A7F6-86830A7A3BC1Q37843473-4A9DAD9A-92E2-4ECA-B8D6-01D6CC737D4BQ38172298-B83027CE-D77C-42E7-A2B1-33E62390196CQ38674134-A90DEAED-6754-4E56-9CCE-A355CCA941BDQ38756596-3EC8A14E-8633-4D73-8AEF-058D03F6D4BAQ38762742-02928A0F-1C91-4F1F-BB4E-9908263BEAB5
P2860
Residual gammaH2AX foci as an indication of lethal DNA lesions.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@ast
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@en
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@nl
type
label
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@ast
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@en
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@nl
prefLabel
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@ast
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@en
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@nl
P2093
P2860
P356
P1433
P1476
Residual gammaH2AX foci as an indication of lethal DNA lesions.
@en
P2093
C Adriana Banuelos
Judit P Banáth
Peggy L Olive
Susan H MacPhail
P2860
P2888
P356
10.1186/1471-2407-10-4
P407
P577
2010-01-05T00:00:00Z
P5875
P6179
1027567789